TAM March/April 2026 Volume 34, Issue 2

On completion of this activity, which contains 9 articles on important new data presented at the 2026 Conference on Retroviruses and Opportunistic Infections, the learner will be better able to: Describe basic science research on HIV, including viral reservoirs and cure List neurologic HIV complications, including coinfections and comorbidities Describe the latest research on antiretroviral therapy for adult, maternal, and pediatric populations with HIV Describe the latest innovations in HIV care and service delivery List the current diagnostic and treatment options for tuberculosis and other opportunistic infections in adults and children with HIV Describe the recent advances in the epidemiology and treatment of viral hepatitis Describe important data on HIV comorbidities List the clinical manifestations and treatment options for acute and postacute COVID-19 Describe the epidemiologic trends and the latest preventative methods for HIV and other sexually transmitted infections

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Target Specialties

Pricing

Free

Reported to ACCME by the provider

Recorded-from-live session
Credit · Up to 12.25 credits
Commercial Support

Released

Apr 30, 2026
Last day to claim credit

May 1, 2027 7 months left

TAM March/April 2026 Volume 34, Issue 2

More from International Antiviral Society-USA (IAS-USA)

More in Infectious Disease